Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!-Reference-Cited by-同舟云学术

Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!

Published:2022-03 Issue: Volume:231 Page:153772
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Cordier Fleur,Van der Meulen Joni,van Roy Nadine,De Wilde Jilke,van Dijck Herwig,Vanhoenacker Filip,Lambrechts Marc,Noyez Valentin,Van de Vijver Koen,Ferdinande Liesbeth,Dendooven Amélie,Van Dorpe Jo,Creytens David

Funder

Fonds Wetenschappelijk Onderzoek

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference28 articles.

1. WHO classification of thoracic tumors, 5th edition 2021.

2. Identification of ALK rearrangements in malignant Peritoneal Mesothelioma;Hung;JAMA Oncol.,2018

3. A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy;Mönch;Oncotarget,2018

4. Molecular characterization of localized pleural mesothelioma;Hung;Mod. Pathol.,2020

5. and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer;Leal;Lung Cancer,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions;Archives of Pathology & Laboratory Medicine;2024-01-08

2. Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack;Cancers;2023-12-06

3. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase–Altered Mesenchymal Tumors;Modern Pathology;2023-12

4. A cutaneous epithelioid vascular tumor harboring a TPM3::ALK fusion;Genes, Chromosomes and Cancer;2023-10-03

5. Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models;Frontiers in Pharmacology;2022-09-06